Pathway to Stop Diabetes Awards
American Diabetes Association (Pathways to Stop Diabetes)
- Internal: 05/02/2018
- Proposal: 07/02/2018
- Amount: Up to $1.625M
- Duration: Up to 7 years
Pathway to Stop Diabetes is a bold, innovative initiative designed to radically transform diabetes research. Our Vision is simple yet revolutionary: find a new generation of brilliant scientists at the peak of their creativity, and provide them with freedom, autonomy, and the financial and professional resources to set them on the road to breakthrough discoveries.
This initiative enables scientists to advance not only their research, but also their careers. Pathway scientists have access to the Mentor Advisory Group, an annual Pathway symposia, select speaking opportunities, and innovative technologies, all designed to foster interactions and collaboration that will enable them to accelerate their research progress.
Initiator Award: This two-phased award is designed to support the transition of scientists from mentored training to independent research faculty.
The awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.
Accelerator Award: This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.
Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.
Visionary Award: Awards are designed to support established, experienced investigators with strong records of outstanding productivity in fields outside of diabetes who are interested in applying their considerable skills and expertise to diabetes research. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes.
Awards provide two distinct phases of research support: Phase 1 provides up to three years of support at a maximum of $325,000 per year (including 30% indirect costs), Phase 2 provides up to two years of support at a maximum of $325,000 per year (including 30% indirect costs). Phase 2 is contingent upon demonstration of significant contributions to the field of diabetes research in Phase 1. Maximum combined support for Phase 1 and Phase 2 is $1,625,000.
Eligibility & Submission Requirements
Each institution is allowed a maximum of one nomination per grant cycle. The nomination can be for any one of the Pathway Program Award types: Initiator (postdoc), Accelerator (early career), or Visionary (established, but not in diabetes research).
If you are interested in submitting, please contact Karen Drew (x4824) by May 2, 2018, and submit a pre-proposal following the NU Procedure for Programs with Limited Submissions
Repeat Submissions: Only one repeat nomination of an individual applicant will be considered; the same individual may not be nominated a third time.